NASDAQ:ATEC Alphatec - ATEC Stock Forecast, Price & News Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Alphatec Holdings, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. $15.60 -0.19 (-1.20%) (As of 03/31/2023 12:00 AM ET) Add Compare Share Share Today's Range$15.48▼$16.1950-Day Range$12.74▼$16.0252-Week Range$5.73▼$16.34Volume1.32 million shsAverage Volume1.03 million shsMarket Capitalization$1.73 billionP/E RatioN/ADividend YieldN/APrice Target$16.25 ProfileAnalyst RatingsChartCompetitorsEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesSEC FilingsShort InterestSocial MediaSustainability Alphatec MarketRank™ ForecastAnalyst RatingModerate Buy2.83 Rating ScoreUpside/Downside4.2% Upside$16.25 Price TargetShort InterestBearish10.57% of Float Sold ShortDividend StrengthN/ASustainability-1.67Upright™ Environmental ScoreNews Sentiment0.67Based on 3 Articles This WeekInsider TradingSelling Shares$969.63 M Sold Last QuarterProj. Earnings GrowthGrowingFrom ($1.04) to ($0.74) Per ShareSee Full Details Hide Full Details Overall MarketRank™MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.1.72 out of 5 starsMedical Sector871st out of 1,004 stocksSurgical & Medical Instruments Industry91st out of 104 stocks 1.4 Analyst's Opinion Consensus RatingAlphatec has received a consensus rating of Buy. The company's average rating score is 2.83, and is based on 5 buy ratings, 1 hold rating, and no sell ratings.Price Target Upside/DownsideAccording to analysts' consensus price target of $16.25, Alphatec has a forecasted upside of 4.2% from its current price of $15.60.Amount of Analyst CoverageAlphatec has only been the subject of 4 research reports in the past 90 days. Previous Next 1.0 Short Interest Percentage of Shares Shorted10.57% of the float of Alphatec has been sold short.Short Interest Ratio / Days to CoverAlphatec has a short interest ratio ("days to cover") of 6.8.Change versus previous monthShort interest in Alphatec has recently increased by 9.30%, indicating that investor sentiment is decreasing significantly. Previous Next 0.0 Dividend Strength Dividend YieldAlphatec does not currently pay a dividend.Dividend GrowthAlphatec does not have a long track record of dividend growth. Previous Next 3.3 Sustainability and ESG Overall ESG (Environmental, Social, and Governance) ScoreAlphatec has received a 37.18% net impact score from Upright. The largest positive contribution comes from its "Physical diseases" impact, which is mostly driven by its "Cervical implants", "Medical screws", and "Lumbar spinal stenosis treatment instruments" products. See details.Environmental SustainabilityThe Environmental Impact score for Alphatec is -1.67. Previous Next 3.1 News and Social Media Coverage News SentimentAlphatec has a news sentiment score of 0.67. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.56 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 3 news articles for Alphatec this week, compared to 2 articles on an average week.Search InterestOnly 4 people have searched for ATEC on MarketBeat in the last 30 days. This is a decrease of -50% compared to the previous 30 days.MarketBeat Follows4 people have added Alphatec to their MarketBeat watchlist in the last 30 days. This is an increase of 100% compared to the previous 30 days. Previous Next 4.2 Company Ownership Insider Buying vs. Insider SellingIn the past three months, Alphatec insiders have sold 3,941,816.47% more of their company's stock than they have bought. Specifically, they have bought $24,598.00 in company stock and sold $969,632,614.00 in company stock.Percentage Held by Insiders33.93% of the stock of Alphatec is held by insiders. A high percentage of insider ownership can be a sign of company health.Percentage Held by Institutions48.59% of the stock of Alphatec is held by institutions. High institutional ownership can be a signal of strong market trust in this company. Previous Next 0.6 Earnings and Valuation Earnings GrowthEarnings for Alphatec are expected to grow in the coming year, from ($1.04) to ($0.74) per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Alphatec is -10.61, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Alphatec is -10.61, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings. Previous Next See Top Rated MarketRank™ Stocks Here About Alphatec (NASDAQ:ATEC) StockAlphatec Holdings, Inc. engages in the design, development, and marketing of spinal fusion technology products and solutions for the treatment of spinal disorders. It offers intra-operative information and neuromonitoring technologies, access systems, interbody implants, fixation systems, and various biologics offerings. The company was founded on March 4, 2005 and is headquartered in Carlsbad, CA.Read More Receive ATEC Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Alphatec and its competitors with MarketBeat's FREE daily newsletter. Email Address ATEC Stock News HeadlinesMarch 25, 2023 | americanbankingnews.comContrasting Orchestra BioMed (NASDAQ:OBIO) and Alphatec (NASDAQ:ATEC)March 24, 2023 | americanbankingnews.comAlphatec (NASDAQ:ATEC) Upgraded by StockNews.com to HoldApril 1, 2023 | Legacy Research (Affiliate) (Ad)Sell every Stock except ONE Markets are down...But Jeff Clark couldn't care less because he ignores almost every stock in the market except ONE. He lives financially free trading this One Stock Once per month...March 23, 2023 | americanbankingnews.comAnalysts Set Alphatec Holdings, Inc. (NASDAQ:ATEC) Price Target at $16.25March 23, 2023 | americanbankingnews.comAlphatec (NASDAQ:ATEC) and Modular Medical (OTC:MODD) Head to Head SurveyMarch 13, 2023 | marketwatch.comEmerging Trends and Future Scenarios of Vertebroplasty & Kyphoplasty Market for the Period 2023-2028 | Latest ResearchFebruary 7, 2023 | finance.yahoo.comATEC to Report Fourth Quarter and Fiscal Year 2022 Financial Results on February 28, 2023January 30, 2023 | marketwatch.comConstruction Chemical Market Size 2023 with Economical Benchmarking, Old Statistics & Forecasts, Company Returns SharesApril 1, 2023 | Legacy Research (Affiliate) (Ad)Sell every Stock except ONE Markets are down...But Jeff Clark couldn't care less because he ignores almost every stock in the market except ONE. He lives financially free trading this One Stock Once per month...December 18, 2022 | marketwatch.comVertebroplasty & Kyphoplasty Market 2023 : Trends, Industry Size, Share, Emerging Trends, Top Leading Players and Forecast 2028December 15, 2022 | marketwatch.comVeterinary Monitors Market Share and Growth Research 2023 | Recent Developments, Demand Scope, Top Manufacturers and Regions Forecast to 2028December 12, 2022 | finance.yahoo.comWith 49% stake, Alphatec Holdings, Inc. (NASDAQ:ATEC) seems to have captured institutional investors' interestNovember 21, 2022 | msn.comAlphatec Holdings's Return On Capital Employed OverviewNovember 9, 2022 | finance.yahoo.comAlphatec Holdings Third Quarter 2022 Earnings: Revenues Beat Expectations, EPS LagsOctober 15, 2022 | seekingalpha.comAlphatec: Not Having My Back (Yet) (NASDAQ:ATEC) - Seeking AlphaOctober 13, 2022 | benzinga.comATEC Launches Expandable Technology for Medialized Posterior Procedure - Alphatec Holdings (NASDAQ:ATEC) - BenzingaOctober 12, 2022 | benzinga.com4 Analysts Have This to Say About Alphatec Holdings - Alphatec Holdings (NASDAQ:ATEC) - BenzingaOctober 12, 2022 | seekingalpha.comATEC rises 10% on raising FY22 guidance, guides Q3 revenue above consensus - Seeking AlphaOctober 12, 2022 | finance.yahoo.comATEC Launches Expandable Technology for Medialized Posterior ProcedureOctober 11, 2022 | streetinsider.comAlphatec Holdings (ATEC) Advances Lateral Sophistication - StreetInsider.comOctober 11, 2022 | marketwatch.comAlphatec Shares Rally After Revenue Guidance >ATEC - MarketWatchOctober 11, 2022 | finance.yahoo.comATEC Advances Lateral SophisticationOctober 10, 2022 | benzinga.comAlphatec Holdings shares are trading higher after the company issued Q3 guidance above estimates. - Alphatec Holdings (NASDAQ:ATEC) - BenzingaOctober 10, 2022 | benzinga.comAlphatec Holdings, Immatics And Some Other Big Stocks Moving Higher On Monday - Belite Bio (NASDAQ:BLTE), - BenzingaOctober 10, 2022 | nasdaq.comAlphatec Holdings Q3 Prel. Sales Rise, Raises FY22 Revenue View; Stock Up - NasdaqOctober 5, 2022 | nasdaq.comWall Street Analysts Believe Alphatec (ATEC) Could Rally 77%: Here's is How to Trade - NasdaqSeptember 29, 2022 | finance.yahoo.comAVITA Medical Appoints Industry Leader James Corbett as Chief Executive Officer - Yahoo FinanceSee More Headlines View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart Receive ATEC Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Alphatec and its competitors with MarketBeat's FREE daily newsletter. Email Address ATEC Company Calendar Last Earnings11/04/2021Today4/01/2023Next Earnings (Estimated)5/04/2023Fiscal Year End12/31/2023Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ Industry Surgical & medical instruments Sub-IndustryHealth Care Equipment SectorMedical Current SymbolNASDAQ:ATEC CUSIP02081G10 CIK1350653 Webwww.atecspine.com Phone(760) 431-9286Fax800-922-1356Employees561Year Founded1990Price Target and Rating Average Stock Price Forecast$16.25 High Stock Price Forecast$20.00 Low Stock Price Forecast$9.50 Forecasted Upside/Downside+4.2%Consensus RatingModerate Buy Rating Score (0-4)2.83 Research Coverage6 Analysts Profitability EPS (Most Recent Fiscal Year)($1.47) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-152,150,000.00 Net Margins-43.36% Pretax Margin-43.32% Return on Equity-575.45% Return on Assets-29.11% Debt Debt-to-Equity Ratio29.74 Current Ratio1.84 Quick Ratio1.11 Sales & Book Value Annual Sales$350.87 million Price / Sales4.94 Cash FlowN/A Price / Cash FlowN/A Book Value($0.35) per share Price / Book-44.57Miscellaneous Outstanding Shares111,110,000Free Float73,410,000Market Cap$1.73 billion OptionableNot Optionable Beta1.25 Social Links Key ExecutivesPatrick S. MilesChairman, President, CEO & COOJ. Todd KoningChief Financial Officer & Executive Vice PresidentKelli M. HowellExecutive Vice President-Clinical StrategiesLuiz PimentaChief Medical OfficerScott LishSenior Vice President-Research & DevelopmentKey CompetitorsAtriCureNASDAQ:ATRCNuVasiveNASDAQ:NUVACardiovascular SystemsNASDAQ:CSIIOrthofix MedicalNASDAQ:OFIXAngioDynamicsNASDAQ:ANGOView All CompetitorsInsiders & InstitutionsMetropolitan Life Insurance Co. NYBought 1,188 shares on 3/31/2023Ownership: 0.004%Patrick MilesSold 60,000 sharesTotal: $960.78 M ($16,013.00/share)James L L TullisSold 30,000 sharesTotal: $483,600.00 ($16.12/share)Patrick MilesSold 60,000 sharesTotal: $949,200.00 ($15.82/share)David SponselSold 16,823 sharesTotal: $266,139.86 ($15.82/share)View All Insider TransactionsView All Institutional Transactions ATEC Stock - Frequently Asked Questions Should I buy or sell Alphatec stock right now? 6 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Alphatec in the last twelve months. There are currently 1 hold rating and 5 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" ATEC shares. View ATEC analyst ratings or view top-rated stocks. What is Alphatec's stock price forecast for 2023? 6 analysts have issued twelve-month price objectives for Alphatec's shares. Their ATEC share price forecasts range from $9.50 to $20.00. On average, they predict the company's share price to reach $16.25 in the next year. This suggests a possible upside of 4.2% from the stock's current price. View analysts price targets for ATEC or view top-rated stocks among Wall Street analysts. How have ATEC shares performed in 2023? Alphatec's stock was trading at $12.35 at the beginning of the year. Since then, ATEC stock has increased by 26.3% and is now trading at $15.60. View the best growth stocks for 2023 here. Are investors shorting Alphatec? Alphatec saw a increase in short interest in the month of March. As of March 15th, there was short interest totaling 6,700,000 shares, an increase of 9.3% from the February 28th total of 6,130,000 shares. Based on an average daily volume of 982,400 shares, the days-to-cover ratio is presently 6.8 days. Currently, 10.6% of the company's stock are short sold. View Alphatec's Short Interest. When is Alphatec's next earnings date? The company is scheduled to release its next quarterly earnings announcement on Thursday, May 4th 2023. View our ATEC earnings forecast. How were Alphatec's earnings last quarter? Alphatec Holdings, Inc. (NASDAQ:ATEC) released its earnings results on Thursday, November, 4th. The medical technology company reported ($0.43) EPS for the quarter, missing the consensus estimate of ($0.23) by $0.20. The medical technology company earned $62.88 million during the quarter, compared to analyst estimates of $61.43 million. Alphatec had a negative net margin of 43.36% and a negative trailing twelve-month return on equity of 575.45%. During the same quarter in the prior year, the firm earned ($0.18) EPS. What ETFs hold Alphatec's stock? ETFs with the largest weight of Alphatec (NASDAQ:ATEC) stock in their portfolio include Jacob Forward ETF (JFWD), SPDR S&P Health Care Equipment ETF (XHE), Invesco Nasdaq Future Gen 200 ETF (QQQS), First Trust Nasdaq Lux Digital Health Solutions ETF (EKG), Principal Healthcare Innovators ETF (BTEC), Global X Aging Population ETF (AGNG).iShares Micro-Cap ETF (IWC) and What guidance has Alphatec issued on next quarter's earnings? Alphatec updated its FY 2023 earnings guidance on Tuesday, February, 28th. The company provided EPS guidance of for the period. The company issued revenue guidance of $438.00 million-$438.00 million, compared to the consensus revenue estimate of $426.30 million. What is Pat Miles' approval rating as Alphatec's CEO? 19 employees have rated Alphatec Chief Executive Officer Pat Miles on Glassdoor.com. Pat Miles has an approval rating of 72% among the company's employees. 63.0% of employees surveyed would recommend working at Alphatec to a friend. What other stocks do shareholders of Alphatec own? Based on aggregate information from My MarketBeat watchlists, some companies that other Alphatec investors own include Macrocure Ltd. - Ordinary Share (MCUR), LinnCo (LNCOQ), California Resources (CRC), Sorrento Therapeutics (SRNE), Catalyst Pharmaceuticals (CPRX), (GBSN) (GBSN), Idera Pharmaceuticals (IDRA), Athersys (ATHX), Anavex Life Sciences (AVXL) and BioCryst Pharmaceuticals (BCRX). What is Alphatec's stock symbol? Alphatec trades on the NASDAQ under the ticker symbol "ATEC." How do I buy shares of Alphatec? Shares of ATEC stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. Compare Top Brokerages Here. What is Alphatec's stock price today? One share of ATEC stock can currently be purchased for approximately $15.60. How much money does Alphatec make? Alphatec (NASDAQ:ATEC) has a market capitalization of $1.73 billion and generates $350.87 million in revenue each year. The medical technology company earns $-152,150,000.00 in net income (profit) each year or ($1.47) on an earnings per share basis. How many employees does Alphatec have? The company employs 561 workers across the globe. How can I contact Alphatec? Alphatec's mailing address is 5818 EL CAMINO REAL, CARLSBAD CA, 92008. The official website for the company is www.atecspine.com. The medical technology company can be reached via phone at (760) 431-9286, via email at ir@alphatecspine.com, or via fax at 800-922-1356. This page (NASDAQ:ATEC) was last updated on 4/1/2023 by MarketBeat.com Staff Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.